Inhibition by acetaminophen of intestinal cancer in rats induced by an aromatic amine similar to food mutagens

European Journal of Cancer Prevention

Volumn 6, Issue 4, 1997, Pages 357-362

  Williams, G M ^a   Iatropoulos, M J ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

Analgesic; Aromatic amine; Chemoprevention; Colon

Indexed keywords

2',3 DIMETHYL 4 BIPHENYLAMINE; PARACETAMOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; COLON CANCER; DOSE RESPONSE; DRUG EFFECT; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ACETAMINOPHEN; AMINOBIPHENYL COMPOUNDS; ANALGESICS, NON-NARCOTIC; ANIMALS; CARCINOGENS; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FOOD CONTAMINATION; INTESTINAL NEOPLASMS; INTESTINE, LARGE; INTESTINE, SMALL; MALE; MUTAGENS; NEOPLASMS, EXPERIMENTAL; RATS; RATS, INBRED F344; SURVIVAL RATE;

EID: 0030731613     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-199708000-00007     Document Type: Article

References (30)

1. Adamson RH, Gustafson J-Å, Ito N et al (1995). Heterocyclic Amines in Cooked Foods: Possible Human Carcinogens, Princeton Scientific Publishing Co. Inc., Princeton, NJ.
2. Davies DS, Gooderham NJ, Murray S et al (1995). Systemic exposure to dietary heterocyclic amines in man. In Heterocyclic Amines in Cooked Foods: Possible Human Carcinogens (eds Adamson RH, Gustafson J-Å, Ito N, et al). Princeton Scientific Publishing Co Inc, Princeton, NJ, pp. 190-6.
3. Fiala ES, Weisburger JH, Katayama S, Chandrasekaran V, Williams GM (1981). The effect of disulfiram on the carcinogenicity of 3,2′-dimethyl-4-aminobiphenyl in Syrian golden hamsters and rats. Carcinogenesis 2: 965-9.
4. Gerhardsson de Verdier M, Hagman U, Peters RK, Steineck G, Overvik E (1991). Meat, cooking methods and colorectal cancer: a case-reference study in Stockholm. Int J Cancer 49: 520-5.
5. Hinson JA, Monks TJ, Hong M, Highet RJ, Pohl LR (1982). 3-(Glutathion-S-yl) acetaminophen: a biliary metabolite of acetaminophen. Drug Metab Dispos 10: 47-50.
6. Iatropoulos, MJ (1986). Morphology of the gastrointestinal tract. In Gastrointestinal Toxicology (eds Rozman, K, Hänninen, O); Elsevier, NYC, NY.
7. Lewis, RJ (1992). Sax's Dangerous Properties of Industrial Materials. Vol. III. Van Nostrand Reinhold, NYC, NY, pp. 1908-15.
8. Kudo T, Narisawa T, Abo S (1980). Antitumor activity of indomethacin on methylazoxymethanol-induced large bowel tumors in rats. Gann 71: 260-4.
9. McNeil Consumer Company/PDR (1995). Tylenol extended relief. In Physicians' Desk Reference, 49th Edition (eds Medical Economics Company): Edward R. Barnhart, Oradell, NJ, pp. 1449-50.
10. Miller EC, Miller JA (1981). Mechanisms of chemical carcinogenesis. Cancer 47: 1055-64.
11. Muscat JE, Stellman SD, Wynder EL (1994). Nonsteroidal antiinflammatory drugs and colorectal cancer. Cancer 74: 1847-54.
12. Muscat JE, Stellman SD, Wynder EL (1995). Analgesic use and colorectal cancer. Rev Med 24: 110-2.
13. Narisawa T, Sato M, Tani M et al (1981). Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. Cancer Res 41: 1954-7.
14. Nigro ND, Bull AW, Boyd ME (1986). Inhibition of intestinal carcinogenesis in rats: effect of difluoromethylornithine with piroxicam of fish oil. J Natl Cancer Inst 77: 1309-13.
15. Pollard M, Luckert PH (1983). Prolonged antitumor effect of indomethacin on autochthonous intestinal tumors in rats. J Natl Cancer Inst 70: 1103-5.
16. Pollard M, Luckert PH (1984). Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitrosourea. Cancer Lett 25: 117-21.
17. Reddy BS, Watanabe K (1978). Effect of intestinal microflora on 3,2′-dimethyl-4-aminobiphenyl-induced carcinogenesis in F344 rats. J Natl Cancer Inst 61: 1269-71.
18. Reddy BS, Maruyama H, Kellogg G (1987). Dose-related inhibition of colon carcinogcncsis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of colon tumor development. Cancer Res 47: 5340-6.
19. Reddy BS, Nayini J, Tokumo K, Rigotty J, Zang E, Kelloff G (1990). Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug, with D,L-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. Cancer Res 50: 2562-8.
20. Reddy BS, Tokumo K, Kulkarni N, Aligia C, Kelloff G (1992). Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds. Carcinogenesis 13: 101-1023.
21. Reddy BS, Rao CV, Rivenson A, Kelloff GJ (1993). Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis 14: 1493-7.
22. Reddy BS (1996). Chemoprevention of colon cancer by dietary constituents and their synthetic analogs. Prev Med 25: 48-50.
23. Siegers C-P, Klaassen CD (1984). Biliary excretion of acetaminophen in ureter ligated rats. Pharmacology 28: 177-90.
24. Sugimura T (1995). History, present and future, of heterocyclic amines, cooked food mutagens. In Heterocyclic Amines in Cooked Foods: Possible Human Carcinogens (eds Adamson RH, Gustafson J-Å, Ito N et al); Princeton Scientific Publishing Co Inc, Princeton, NJ, USA, pp. 214-31.
25. Wargovich MJ, Chen CD, Harris C, Yang E, Velasco M (1995). Inhibition of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiation agents in the rat colon. Int J Cancer 60: 515-9.
26. 2-fluorenylacetamide as a key ultimate carcinogen. Cancer Res 32: 491-500.
27. 2-fluorenylacetamide in mice, hamsters, and female rats. J Natl Cancer Inst 51: 235-40.
28. Weisburger JH, Fiala ES (1983). Experimental colon carcinogens and their mode of action. In Experimental Colon Carcinogenesis (eds Autrup H, Williams GM); CRC Press, Boca Raton, FL, pp. 27-50.
29. Weisburger JH, Williams GM (1995). Causes of cancer. In American Cancer Society Textbook of Clinical Oncology (eds Murphy GP, Lawrence Jr W, Lenhard Jr RE); American Cancer Society, Inc, Atlanta, GA. pp. 10-39.
30. 2-fluorenylacetamide. Cancer Res 33: 454-7.